Pickering LM - Search Results

1

Endobronchial metastases from renal cell carcinoma: a late manifestation of the disease with an increasing incidence.

Khattak MA, Fisher RA, Pickering LM, Gore ME, Larkin JM. Khattak MA, et al. Among authors: pickering lm. BJU Int. 2012 Nov;110(10):1407-8. doi: 10.1111/j.1464-410X.2012.11442.x. Epub 2012 Sep 3. BJU Int. 2012. PMID: 22937754 No abstract available.

2

Sunitinib is superior to interferon alpha with respect to quality of life for patients with renal cell carcinoma.

Pickering LM, Pyle L, Larkin JM. Pickering LM, et al. Nat Clin Pract Oncol. 2009 Jan;6(1):6-7. doi: 10.1038/ncponc1283. Nat Clin Pract Oncol. 2009. PMID: 19096396

3

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinib.

Larkin J, Fisher R, Pickering L, Thway K, Livni N, Fisher C, Gore M. Larkin J, et al. J Clin Oncol. 2010 Oct 1;28(28):e539-40. doi: 10.1200/JCO.2010.30.1457. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679595 No abstract available.

4

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.

Larkin JM, Ferguson TR, Pickering LM, Edmonds K, James MG, Thomas K, Banerji U, Berns B, de Boer C, Gore ME. Larkin JM, et al. Among authors: pickering lm. Br J Cancer. 2010 Oct 12;103(8):1149-53. doi: 10.1038/sj.bjc.6605889. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842130 Free PMC article. Clinical Trial.

5

Sunitinib for metastatic renal cell carcinoma.

Mukherji D, Larkin J, Pickering L. Mukherji D, et al. Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.

6

Does axitinib (AG-01376) have a future role in metastatic renal cell carcinoma and other malignancies?

Goldstein R, Pickering L, Larkin J. Goldstein R, et al. Expert Rev Anticancer Ther. 2010 Oct;10(10):1545-57. doi: 10.1586/era.10.134. Expert Rev Anticancer Ther. 2010. PMID: 20942625 Review.

7

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings.

Okera M, Chan S, Dernede U, Larkin J, Popat S, Gilbert D, Jones L, Osuji N, Sykes H, Oakley C, Pickering L, Lofts F, Chowdhury S. Okera M, et al. Br J Cancer. 2011 Feb 1;104(3):407-12. doi: 10.1038/sj.bjc.6606059. Epub 2010 Dec 21. Br J Cancer. 2011. PMID: 21179036 Free PMC article.

8

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.

Josephs D, Hutson TE, Cowey CL, Pickering LM, Larkin JM, Gore ME, Van Hemelrijck M, McDermott DF, Powles T, Chowdhury P, Karapetis C, Harper PG, Choueiri TK, Chowdhury S. Josephs D, et al. Among authors: pickering lm. BJU Int. 2011 Oct;108(8):1279-83. doi: 10.1111/j.1464-410X.2010.09990.x. Epub 2011 Jan 18. BJU Int. 2011. PMID: 21244613

9

Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimus.

Larkin JM, Fisher RA, Pickering LM, Sohaib SA, Ghosn M, Christmas T, Cordiner RL, Gore ME. Larkin JM, et al. Among authors: pickering lm. J Clin Oncol. 2011 Mar 20;29(9):e241-2. doi: 10.1200/JCO.2010.33.4375. Epub 2011 Jan 18. J Clin Oncol. 2011. PMID: 21245426 No abstract available.

10

Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action.

Larkin J, Swanton C, Pickering L. Larkin J, et al. Expert Rev Anticancer Ther. 2011 Apr;11(4):639-49. doi: 10.1586/era.11.21. Expert Rev Anticancer Ther. 2011. PMID: 21504330 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters